From the UCLA Center for World Health’s 2017-18 Annual Report:
Jonathan Flint, MD, of UCLA’s Brain Research Institute, is partnering with Shanghai Jiaotong University in China to analyze the genetic basis of major depressive disorder. With funding from the Wellcome Trust, this study will enroll 48,000 people, with the goal of identifying at least 30 genome-wide significant factors that contribute to the risk of depression.
To date, six hospitals have been recruited and the team has developed a tablet-based interview system and a pipeline for blood collection and DNA extraction.